SCHERING-PLOUGH CAN ENTER GENERIC ALBUTEROL MDI MARKET "EXTREMELY FAST" THROUGH WARRICK SUBSIDIARY, FIRM TELLS ANALYSTS; PROVENTIL U.S. SALES AHEAD 30%

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".